ARTELO BIOSCIENCES, INC. Deferred Tax Assets, Valuation Allowance
ARTELO BIOSCIENCES, INC. (ARTL) had Deferred Tax Assets, Valuation Allowance of $7.82 million as of 2025-12-31, per its 8-K filed 2026-03-17.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-17
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $7.82M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $5.68M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $5.13M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $4.34M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $7.82M 8-K · filed 2026-03-17 | |
| 2024-12-31 | $5.68M 8-K · filed 2026-03-17 | |
| 2023-12-31 | $5.13M 8-K · filed 2025-07-11 | |
| 2022-12-31 | $4.34M 10-K · filed 2024-03-25 | |
| 2021-12-31 | $3.34M 10-K · filed 2023-03-31 | $3.69M 10-KT · filed 2022-03-21 |
| 2021-08-31 | $3.86M 10-K · filed 2023-03-31 | $3.04M 10-K · filed 2021-11-29 |
| 2020-08-31 | $1.80M 10-KT · filed 2022-03-21 | $1.80M 10-K · filed 2020-11-04 |
| 2019-08-31 | $1.06M 10-K · filed 2020-11-04 | |
| 2018-08-31 | $578.96K 10-K/A · filed 2019-12-18 | |
| 2017-08-31 | $100.33K 10-K · filed 2018-11-29 | |
| 2016-08-31 | $20.47K 10-K · filed 2017-11-29 | |
| 2015-08-31 | $10.37K 10-K · filed 2016-11-29 | -$10.37K 10-K · filed 2015-12-11 |
| 2015-05-31 | -$8.81K 10-Q · filed 2015-07-15 | |
| 2015-02-28 | $7.96K 10-Q · filed 2015-04-14 | |
| 2014-08-31 | -$5.19K 10-K · filed 2015-12-11 | $5.19K 10-Q · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |